Clinically significant response to zolpidem in disorders of consciousness secondary to anti-N-methyl-d-aspartate receptor encephalitis in a teenager: A case report

Pediatric Neurology

Volumn 50, Issue 3, 2014, Pages 262-264

  Appu, Merveen ^a   Noetzel, Michael ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

anti N methyl d aspartate receptor encephalitis; disorders of consciousness; minimally conscious state; neurorehabilitation; zolpidem

Indexed keywords

ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; DISORDERS OF CONSCIOUSNESS; MINIMALLY CONSCIOUS STATE; NEUROREHABILITATION; ZOLPIDEM;

ADOLESCENT; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; CENTRAL NERVOUS SYSTEM AGENTS; CONSCIOUSNESS DISORDERS; FEMALE; HOSPITALIZATION; HUMANS; IMMUNOTHERAPY; PYRIDINES; RECOVERY OF FUNCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84894177710     PISSN: 08878994     EISSN: 18735150     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2013.11.001     Document Type: Article

References (15)

1. J. Dalmau, E. Tuzun, and H.Y. Wu et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma Ann Neurol 61 2007 25 36
2. M.S. Gable, H. Sheriff, and J. Dalmau et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project Clin Infect Dis 54 2012 899 904
3. J. Dalmau, A.J. Gleichman, and E.G. Hughes et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies Lancet Neurol 7 2008 1091 1098
4. M.J. Titulaer, L. McCracken, and I. Gabilondo et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study Lancet Neurol 12 2013 157 165
5. C. Machado, M. Estévez, and J. Pérez-Nellar et al. Autonomic, EEG, and behavioral arousal signs in a PVS case after zolpidem intake Can J Neurol Sci 38 2011 341 344
6. L. Oliveira, and F. Fregni Pharmacological and electrical stimulation in chronic disorders of consciousness: new insights and future directions Brain Inj 25 2011 315 327
7. J.L. Shames, and H. Ring Transient reversal of anoxic brain injury-related minimally conscious state after zolpidem administration: a case report Arch Phys Med Rehabil 89 2008 386 388
8. S.I. Cohen, and T.T. Duong Increased arousal in a patient with anoxic brain injury after administration of zolpidem Am J Phys Med Rehabil 87 2008 229 231
9. I. Berlin, D. Warot, and T. Hergueta et al. Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects J Clin Psychopharmacol 13 1992 100 106
10. J. Whyte, and R. Myers Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: a preliminary placebo controlled trial Am J Phys Med Rehabil 88 2009 410 418
11. N. Snyman, J.R. Egan, and K. London et al. Zolpidem for persistent vegetative state-a placebo-controlled trial in pediatrics Neuropediatrics 41 2010 223 227
12. R.P. Clauss Neurotransmitters in disorders of consciousness and brain damage Med Hypotheses 77 2011 209 213
13. F. Pistoia, E. Mura, and S. Govoni et al. Awakenings and awareness recovery in disorders of consciousness: is there a role for drugs? CNS Drugs 24 2010 625 638
14. M. Georgiopoulos, P. Katsakiori, and Z. Kefalopoulou et al. Vegetative state and minimally conscious state: a review of the therapeutic interventions Stereotact Funct Neurosurg 88 2010 199 207
15. S.D. Hall, N. Yamawaki, and A.E. Fisher et al. GABA (A) alpha-1 subunit mediated desynchronization of elevated low frequency oscillations alleviates specific dysfunction in stroke-a case report Clin Neurophysiol 121 2010 549 555